Literature DB >> 15795255

A substitution in rous sarcoma virus integrase that separates its two biologically relevant enzymatic activities.

Wesley M Konsavage1, Stephen Burkholder, Malgorzata Sudol, Amy L Harper, Michael Katzman.   

Abstract

Retroviral integrase prepares viral DNA for integration by removing 2 nucleotides from each end of unintegrated DNA in a reaction referred to as processing. However, it has been known since the processing assay was first described that avian integrases frequently nick 3 nucleotides, as well as 2 nucleotides, from viral DNA ends when reaction mixtures contain Mn2+. We now report that specificity for the biologically relevant "-2" site is enhanced when the serine at amino acid 124 of Rous sarcoma virus (RSV) integrase is replaced by alanine, valine, glycine, lysine, or aspartate. The protein with a serine-to-aspartate substitution exhibited especially high fidelity for the correct site, as evidenced by a ratio of -2 nicks to -3 nicks that was more than 40-fold greater than that for the wild-type enzyme in reactions with Mn2+. Even with Mg2+, the substituted proteins exhibited greater specificity than the wild type, especially the S124D protein. Moreover, this protein was more efficient than the wild type at processing viral DNA ends. Unexpectedly, however, the S124D protein was significantly impaired at catalyzing the insertion of viral DNA ends in reactions with Mn2+ and joining was undetectable in reactions with Mg2+. Thus, the S124D protein has separated the processing and joining activities of integrase. Similar results were found for human immunodeficiency virus integrase with the analogous substitution. No proteins with comparable properties have been described. Moreover, RSV virions containing integrase with the S124D mutation were unable to replicate in cell cultures. Together, these data suggest that integrase has evolved to have submaximal processing activity so that it can also catalyze DNA joining.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15795255      PMCID: PMC1069555          DOI: 10.1128/JVI.79.8.4691-4699.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

Review 1.  Substrate recognition by retroviral integrases.

Authors:  M Katzman; R A Katz
Journal:  Adv Virus Res       Date:  1999       Impact factor: 9.937

2.  Mapping target site selection for the non-specific nuclease activities of retroviral integrase.

Authors:  M Katzman; M Sudol; J S Pufnock; S Zeto; L M Skinner
Journal:  Virus Res       Date:  2000-01       Impact factor: 3.303

3.  Subterminal viral DNA nucleotides as specific recognition signals for human immunodeficiency virus type 1 and visna virus integrases under magnesium-dependent conditions.

Authors:  A L Morgan; M Katzman
Journal:  J Gen Virol       Date:  2000-03       Impact factor: 3.891

4.  An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA.

Authors:  Amy L Harper; Malgorzata Sudol; Michael Katzman
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  Nucleophile selection for the endonuclease activities of human, ovine, and avian retroviral integrases.

Authors:  L M Skinner; M Sudol; A L Harper; M Katzman
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

6.  Analysis of conserved and non-conserved amino acids critical for ALSV (Avian leukemia and sarcoma viruses) integrase functions in vitro.

Authors:  K Moreau; C Faure; G Verdier; C Ronfort
Journal:  Arch Virol       Date:  2002-09       Impact factor: 2.574

7.  Use of patient-derived human immunodeficiency virus type 1 integrases to identify a protein residue that affects target site selection.

Authors:  A L Harper; L M Skinner; M Sudol; M Katzman
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

8.  Activity of HIV-1 integrases recovered from subjects with varied rates of disease progression.

Authors:  M Katzman; A L Harper; M Sudol; L M Skinner; M E Eyster
Journal:  J Acquir Immune Defic Syndr       Date:  2001-11-01       Impact factor: 3.731

9.  Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail.

Authors:  C Moscovici; M G Moscovici; H Jimenez; M M Lai; M J Hayman; P K Vogt
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

10.  Biochemical and random mutagenesis analysis of the region carrying the catalytic E152 amino acid of HIV-1 integrase.

Authors:  C Calmels; V Richard de Soultrait; A Caumont; C Desjobert; A Faure; M Fournier; L Tarrago-Litvak; V Parissi
Journal:  Nucleic Acids Res       Date:  2004-03-03       Impact factor: 16.971

View more
  4 in total

1.  Division of labor within human immunodeficiency virus integrase complexes: determinants of catalysis and target DNA capture.

Authors:  Tracy L Diamond; Frederic D Bushman
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Defining the DNA substrate binding sites on HIV-1 integrase.

Authors:  James Dolan; Aiping Chen; Irene T Weber; Robert W Harrison; Jonathan Leis
Journal:  J Mol Biol       Date:  2008-11-07       Impact factor: 5.469

3.  The mechanism of retroviral integration from X-ray structures of its key intermediates.

Authors:  Goedele N Maertens; Stephen Hare; Peter Cherepanov
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

4.  Structural basis of second-generation HIV integrase inhibitor action and viral resistance.

Authors:  Nicola J Cook; Wen Li; Dénes Berta; Magd Badaoui; Allison Ballandras-Colas; Andrea Nans; Abhay Kotecha; Edina Rosta; Alan N Engelman; Peter Cherepanov
Journal:  Science       Date:  2020-01-30       Impact factor: 47.728

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.